Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Core Binding Factor Alpha 1 Subunit | 106 | 2024 | 144 | 12.080 |
Why?
|
Osteoblasts | 101 | 2024 | 204 | 11.040 |
Why?
|
Osteogenesis | 52 | 2024 | 149 | 7.420 |
Why?
|
Cell Differentiation | 106 | 2024 | 1295 | 7.050 |
Why?
|
MicroRNAs | 32 | 2024 | 617 | 5.220 |
Why?
|
Epigenesis, Genetic | 45 | 2024 | 350 | 4.970 |
Why?
|
Transcription Factors | 90 | 2024 | 1456 | 4.730 |
Why?
|
Bone Neoplasms | 23 | 2016 | 117 | 4.060 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 34 | 2023 | 86 | 3.970 |
Why?
|
Gene Expression Regulation, Neoplastic | 43 | 2024 | 484 | 3.240 |
Why?
|
RNA, Long Noncoding | 8 | 2024 | 152 | 3.170 |
Why?
|
Breast Neoplasms | 30 | 2023 | 1126 | 3.090 |
Why?
|
Prostatic Neoplasms | 14 | 2024 | 326 | 2.990 |
Why?
|
Bone and Bones | 24 | 2017 | 155 | 2.920 |
Why?
|
Gene Expression Regulation | 67 | 2022 | 1537 | 2.900 |
Why?
|
Gene Expression Regulation, Developmental | 36 | 2020 | 630 | 2.810 |
Why?
|
Transcription, Genetic | 53 | 2019 | 847 | 2.730 |
Why?
|
Promoter Regions, Genetic | 60 | 2020 | 659 | 2.680 |
Why?
|
Animals | 224 | 2024 | 19607 | 2.430 |
Why?
|
Histones | 46 | 2023 | 463 | 2.410 |
Why?
|
Cell Proliferation | 53 | 2024 | 944 | 2.380 |
Why?
|
Mice | 141 | 2024 | 10253 | 2.270 |
Why?
|
Triple Negative Breast Neoplasms | 5 | 2024 | 59 | 2.130 |
Why?
|
Chondrocytes | 15 | 2021 | 42 | 2.110 |
Why?
|
Cell Nucleus | 56 | 2018 | 603 | 2.090 |
Why?
|
Homeodomain Proteins | 14 | 2015 | 254 | 2.070 |
Why?
|
Cell Line, Tumor | 60 | 2024 | 1370 | 2.050 |
Why?
|
Signal Transduction | 48 | 2023 | 2890 | 2.020 |
Why?
|
Chromatin Assembly and Disassembly | 16 | 2018 | 229 | 1.990 |
Why?
|
Bone Development | 13 | 2015 | 33 | 1.980 |
Why?
|
Transforming Growth Factor beta | 14 | 2010 | 162 | 1.920 |
Why?
|
Neoplasm Proteins | 28 | 2015 | 276 | 1.890 |
Why?
|
Bone Morphogenetic Proteins | 13 | 2016 | 64 | 1.890 |
Why?
|
DNA-Binding Proteins | 36 | 2022 | 1128 | 1.870 |
Why?
|
Cell Lineage | 25 | 2022 | 250 | 1.770 |
Why?
|
Mitosis | 23 | 2022 | 208 | 1.730 |
Why?
|
Chromatin | 34 | 2023 | 594 | 1.700 |
Why?
|
Osteocalcin | 28 | 2018 | 48 | 1.700 |
Why?
|
Biomarkers, Tumor | 6 | 2024 | 454 | 1.690 |
Why?
|
Nuclear Proteins | 29 | 2024 | 759 | 1.570 |
Why?
|
Neoplasms | 17 | 2024 | 1234 | 1.400 |
Why?
|
Cell Cycle | 31 | 2023 | 379 | 1.360 |
Why?
|
Up-Regulation | 17 | 2018 | 363 | 1.350 |
Why?
|
Gene Regulatory Networks | 7 | 2016 | 139 | 1.340 |
Why?
|
Humans | 199 | 2024 | 59302 | 1.280 |
Why?
|
Smad Proteins | 5 | 2015 | 20 | 1.270 |
Why?
|
Transcriptional Activation | 25 | 2020 | 188 | 1.250 |
Why?
|
Embryonic Stem Cells | 14 | 2017 | 150 | 1.210 |
Why?
|
Calcification, Physiologic | 9 | 2019 | 20 | 1.200 |
Why?
|
Cell Line | 50 | 2019 | 2014 | 1.190 |
Why?
|
Repressor Proteins | 21 | 2019 | 336 | 1.170 |
Why?
|
Osteosarcoma | 17 | 2020 | 53 | 1.140 |
Why?
|
Gene Expression Profiling | 25 | 2018 | 697 | 1.100 |
Why?
|
Receptors, Calcitriol | 16 | 2019 | 32 | 1.090 |
Why?
|
Genome | 5 | 2017 | 253 | 1.060 |
Why?
|
Fracture Healing | 4 | 2014 | 25 | 1.050 |
Why?
|
Down-Regulation | 15 | 2018 | 306 | 1.000 |
Why?
|
Cell Movement | 11 | 2017 | 422 | 1.000 |
Why?
|
Homeostasis | 6 | 2023 | 340 | 0.990 |
Why?
|
Rats | 41 | 2021 | 1907 | 0.950 |
Why?
|
Bone Diseases | 2 | 2014 | 21 | 0.940 |
Why?
|
Bone Morphogenetic Protein 2 | 14 | 2018 | 48 | 0.930 |
Why?
|
Osteolysis | 4 | 2014 | 17 | 0.900 |
Why?
|
Phenotype | 29 | 2022 | 1155 | 0.900 |
Why?
|
Stem Cells | 12 | 2014 | 257 | 0.900 |
Why?
|
Intercellular Signaling Peptides and Proteins | 9 | 2012 | 158 | 0.860 |
Why?
|
DNA Helicases | 8 | 2018 | 187 | 0.810 |
Why?
|
Wnt Signaling Pathway | 4 | 2019 | 71 | 0.780 |
Why?
|
Cells, Cultured | 36 | 2024 | 2103 | 0.740 |
Why?
|
Mesoderm | 12 | 2016 | 83 | 0.740 |
Why?
|
DNA | 18 | 2017 | 793 | 0.740 |
Why?
|
Cell Cycle Proteins | 18 | 2024 | 375 | 0.740 |
Why?
|
Osteoclasts | 9 | 2024 | 50 | 0.720 |
Why?
|
Wnt Proteins | 8 | 2013 | 91 | 0.700 |
Why?
|
Core Binding Factor beta Subunit | 10 | 2023 | 24 | 0.690 |
Why?
|
Bone Remodeling | 7 | 2015 | 25 | 0.680 |
Why?
|
Deoxyribonucleases | 2 | 2017 | 30 | 0.660 |
Why?
|
Protein Binding | 30 | 2019 | 1550 | 0.660 |
Why?
|
Fractures, Bone | 3 | 2011 | 137 | 0.650 |
Why?
|
Cissus | 4 | 2020 | 4 | 0.630 |
Why?
|
Chondrogenesis | 6 | 2021 | 9 | 0.630 |
Why?
|
RNA Interference | 18 | 2017 | 589 | 0.630 |
Why?
|
Mice, Knockout | 24 | 2021 | 1987 | 0.620 |
Why?
|
CCCTC-Binding Factor | 2 | 2017 | 40 | 0.620 |
Why?
|
Gene Expression | 14 | 2019 | 808 | 0.620 |
Why?
|
Embryo, Mammalian | 11 | 2013 | 161 | 0.620 |
Why?
|
Transforming Growth Factor beta1 | 5 | 2023 | 53 | 0.620 |
Why?
|
Chromosomal Proteins, Non-Histone | 7 | 2014 | 156 | 0.600 |
Why?
|
Membrane Proteins | 5 | 2016 | 843 | 0.600 |
Why?
|
Models, Biological | 20 | 2017 | 1139 | 0.590 |
Why?
|
Proto-Oncogene Proteins | 11 | 2005 | 315 | 0.590 |
Why?
|
Genetic Predisposition to Disease | 5 | 2019 | 677 | 0.580 |
Why?
|
Mice, Transgenic | 18 | 2016 | 1221 | 0.580 |
Why?
|
Carcinogenesis | 6 | 2018 | 115 | 0.580 |
Why?
|
RNA, Messenger | 26 | 2020 | 1470 | 0.570 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2017 | 54 | 0.570 |
Why?
|
Titanium | 3 | 2024 | 58 | 0.570 |
Why?
|
Plant Extracts | 4 | 2020 | 160 | 0.560 |
Why?
|
RNA, Untranslated | 5 | 2015 | 101 | 0.560 |
Why?
|
Human Embryonic Stem Cells | 5 | 2017 | 33 | 0.560 |
Why?
|
Multigene Family | 3 | 2023 | 93 | 0.550 |
Why?
|
Oxidoreductases | 6 | 2016 | 65 | 0.550 |
Why?
|
Disease Progression | 13 | 2018 | 1039 | 0.540 |
Why?
|
Multiprotein Complexes | 6 | 2015 | 150 | 0.540 |
Why?
|
Female | 52 | 2023 | 30799 | 0.540 |
Why?
|
Adenocarcinoma | 4 | 2016 | 322 | 0.540 |
Why?
|
Trans-Activators | 9 | 2007 | 295 | 0.530 |
Why?
|
Base Sequence | 23 | 2014 | 1312 | 0.530 |
Why?
|
Nuclear Matrix | 13 | 2017 | 28 | 0.530 |
Why?
|
Genome, Human | 5 | 2018 | 219 | 0.530 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2015 | 62 | 0.520 |
Why?
|
Fibroblasts | 8 | 2016 | 367 | 0.510 |
Why?
|
Proteins | 9 | 2008 | 742 | 0.510 |
Why?
|
Interleukin-11 | 1 | 2015 | 8 | 0.510 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 13 | 0.510 |
Why?
|
Bone Resorption | 4 | 2015 | 49 | 0.500 |
Why?
|
Epithelial-Mesenchymal Transition | 5 | 2020 | 60 | 0.500 |
Why?
|
Pluripotent Stem Cells | 7 | 2015 | 67 | 0.490 |
Why?
|
Core Binding Factor alpha Subunits | 15 | 2018 | 20 | 0.480 |
Why?
|
Biomarkers | 9 | 2014 | 1205 | 0.470 |
Why?
|
Hydroxamic Acids | 3 | 2011 | 27 | 0.470 |
Why?
|
Cartilage | 5 | 2014 | 36 | 0.470 |
Why?
|
3T3 Cells | 12 | 2019 | 108 | 0.460 |
Why?
|
HeLa Cells | 18 | 2014 | 527 | 0.460 |
Why?
|
DEAD-box RNA Helicases | 2 | 2016 | 77 | 0.450 |
Why?
|
Vitamin D | 9 | 2010 | 149 | 0.450 |
Why?
|
Mice, SCID | 8 | 2020 | 506 | 0.450 |
Why?
|
RNA, Neoplasm | 2 | 2012 | 34 | 0.440 |
Why?
|
Neoplasm Metastasis | 8 | 2012 | 196 | 0.440 |
Why?
|
Boronic Acids | 2 | 2010 | 27 | 0.430 |
Why?
|
Leukotriene Antagonists | 2 | 2010 | 9 | 0.430 |
Why?
|
Pyrazines | 2 | 2010 | 32 | 0.430 |
Why?
|
Tumor Suppressor Proteins | 7 | 2020 | 193 | 0.430 |
Why?
|
G1 Phase | 9 | 2018 | 53 | 0.430 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2010 | 131 | 0.420 |
Why?
|
Microscopy, Fluorescence | 15 | 2013 | 397 | 0.410 |
Why?
|
Blotting, Western | 15 | 2017 | 595 | 0.410 |
Why?
|
Hedgehog Proteins | 3 | 2008 | 113 | 0.410 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2012 | 30 | 0.410 |
Why?
|
Male | 37 | 2024 | 27481 | 0.410 |
Why?
|
Protease Inhibitors | 2 | 2010 | 104 | 0.410 |
Why?
|
Embryonic Development | 2 | 2016 | 136 | 0.410 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 15 | 2014 | 525 | 0.400 |
Why?
|
Binding Sites | 15 | 2015 | 875 | 0.400 |
Why?
|
Cartilage, Articular | 3 | 2023 | 73 | 0.400 |
Why?
|
DNA Methylation | 10 | 2017 | 274 | 0.390 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2017 | 192 | 0.390 |
Why?
|
Chromatin Immunoprecipitation | 11 | 2017 | 145 | 0.390 |
Why?
|
Mice, Inbred C57BL | 19 | 2022 | 3186 | 0.390 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2016 | 299 | 0.390 |
Why?
|
Models, Genetic | 11 | 2012 | 253 | 0.370 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2010 | 31 | 0.370 |
Why?
|
RNA | 5 | 2020 | 404 | 0.370 |
Why?
|
Cell Survival | 4 | 2024 | 553 | 0.370 |
Why?
|
MCF-7 Cells | 5 | 2018 | 65 | 0.370 |
Why?
|
RNA, Ribosomal | 6 | 2016 | 53 | 0.370 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2010 | 2 | 0.370 |
Why?
|
Leukotrienes | 1 | 2010 | 6 | 0.360 |
Why?
|
Arachidonic Acid | 1 | 2010 | 39 | 0.360 |
Why?
|
Eicosanoids | 1 | 2010 | 25 | 0.360 |
Why?
|
Transfection | 16 | 2017 | 673 | 0.350 |
Why?
|
Neoplastic Stem Cells | 4 | 2020 | 201 | 0.350 |
Why?
|
Mutation | 17 | 2022 | 2427 | 0.350 |
Why?
|
Vitamin D3 24-Hydroxylase | 2 | 2020 | 7 | 0.350 |
Why?
|
Genomics | 4 | 2018 | 314 | 0.340 |
Why?
|
RNA, Small Interfering | 12 | 2016 | 851 | 0.340 |
Why?
|
Receptors, Leukotriene | 1 | 2009 | 3 | 0.340 |
Why?
|
Endoribonucleases | 1 | 2010 | 52 | 0.340 |
Why?
|
DNA Damage | 7 | 2015 | 277 | 0.330 |
Why?
|
Molecular Sequence Data | 14 | 2014 | 1977 | 0.330 |
Why?
|
Tibial Fractures | 1 | 2009 | 12 | 0.330 |
Why?
|
Regulatory Sequences, Nucleic Acid | 5 | 2007 | 96 | 0.330 |
Why?
|
Epithelial Cells | 6 | 2020 | 375 | 0.330 |
Why?
|
Phosphoproteins | 3 | 2012 | 216 | 0.330 |
Why?
|
Inflammation Mediators | 1 | 2010 | 169 | 0.330 |
Why?
|
Tibia | 1 | 2009 | 70 | 0.320 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2008 | 6 | 0.320 |
Why?
|
Genes, Switch | 1 | 2008 | 6 | 0.310 |
Why?
|
Translocation, Genetic | 7 | 2017 | 64 | 0.310 |
Why?
|
DNA Replication | 5 | 2016 | 229 | 0.310 |
Why?
|
Genomic Instability | 4 | 2018 | 53 | 0.310 |
Why?
|
Amino Acids | 2 | 2008 | 140 | 0.300 |
Why?
|
Bone Diseases, Metabolic | 2 | 2022 | 21 | 0.300 |
Why?
|
Cleidocranial Dysplasia | 5 | 2014 | 9 | 0.290 |
Why?
|
Neoplasm Transplantation | 3 | 2018 | 158 | 0.290 |
Why?
|
Skull | 5 | 2014 | 57 | 0.290 |
Why?
|
Thyroid Hormone Receptors beta | 2 | 2018 | 5 | 0.290 |
Why?
|
Cholecalciferol | 5 | 2020 | 27 | 0.290 |
Why?
|
Tumor Cells, Cultured | 12 | 2010 | 454 | 0.290 |
Why?
|
Inflammation | 2 | 2012 | 1101 | 0.290 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 3 | 2014 | 21 | 0.280 |
Why?
|
Tumor Microenvironment | 5 | 2020 | 141 | 0.280 |
Why?
|
Bone Marrow Cells | 6 | 2014 | 231 | 0.280 |
Why?
|
Kidney | 2 | 2008 | 391 | 0.280 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2014 | 59 | 0.280 |
Why?
|
3' Untranslated Regions | 5 | 2016 | 84 | 0.270 |
Why?
|
Protein Transport | 14 | 2012 | 394 | 0.270 |
Why?
|
Sialoglycoproteins | 5 | 2012 | 20 | 0.270 |
Why?
|
DNA Repair | 3 | 2016 | 230 | 0.270 |
Why?
|
Nucleosomes | 7 | 2017 | 185 | 0.270 |
Why?
|
Computational Biology | 6 | 2017 | 325 | 0.270 |
Why?
|
Chromosomes, Human, Pair 8 | 6 | 2017 | 22 | 0.260 |
Why?
|
Chromosomes, Human, Pair 21 | 6 | 2017 | 27 | 0.260 |
Why?
|
Hematopoiesis | 4 | 2013 | 123 | 0.260 |
Why?
|
Neoplasm Invasiveness | 5 | 2017 | 242 | 0.260 |
Why?
|
RANK Ligand | 4 | 2016 | 24 | 0.260 |
Why?
|
RUNX1 Translocation Partner 1 Protein | 6 | 2017 | 11 | 0.260 |
Why?
|
Lysine | 2 | 2016 | 75 | 0.260 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 123 | 0.260 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 2 | 2015 | 18 | 0.260 |
Why?
|
Protein Processing, Post-Translational | 6 | 2020 | 255 | 0.250 |
Why?
|
Cell Cycle Checkpoints | 2 | 2016 | 44 | 0.250 |
Why?
|
Intranuclear Space | 3 | 2010 | 5 | 0.250 |
Why?
|
Chromosomes | 5 | 2016 | 133 | 0.250 |
Why?
|
Gene Knockdown Techniques | 6 | 2017 | 193 | 0.250 |
Why?
|
Alkaline Phosphatase | 6 | 2019 | 42 | 0.250 |
Why?
|
Animals, Newborn | 3 | 2008 | 230 | 0.250 |
Why?
|
Parathyroid Hormone-Related Protein | 3 | 2016 | 9 | 0.250 |
Why?
|
Oligonucleotide Array Sequence Analysis | 9 | 2011 | 291 | 0.240 |
Why?
|
Time Factors | 14 | 2014 | 3567 | 0.240 |
Why?
|
Apoptosis | 8 | 2017 | 1038 | 0.240 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2015 | 163 | 0.230 |
Why?
|
Amino Acid Sequence | 8 | 2009 | 1582 | 0.230 |
Why?
|
Radiography | 3 | 2010 | 505 | 0.230 |
Why?
|
Axin Protein | 2 | 2014 | 10 | 0.220 |
Why?
|
Cell Self Renewal | 1 | 2023 | 12 | 0.220 |
Why?
|
Protein Structure, Tertiary | 13 | 2010 | 663 | 0.220 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2018 | 324 | 0.220 |
Why?
|
Osteopontin | 5 | 2019 | 22 | 0.220 |
Why?
|
Brain | 3 | 2008 | 1487 | 0.220 |
Why?
|
Adenosine Triphosphatases | 4 | 2017 | 250 | 0.220 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 194 | 0.220 |
Why?
|
Point Mutation | 5 | 2013 | 162 | 0.220 |
Why?
|
Bone Density | 5 | 2022 | 173 | 0.220 |
Why?
|
Ribonuclease III | 2 | 2016 | 81 | 0.210 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2005 | 13 | 0.210 |
Why?
|
Hypertrophy | 3 | 2009 | 30 | 0.210 |
Why?
|
Interphase | 5 | 2016 | 66 | 0.210 |
Why?
|
Circulating MicroRNA | 1 | 2022 | 6 | 0.210 |
Why?
|
Calcitriol | 4 | 2010 | 22 | 0.210 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2022 | 25 | 0.200 |
Why?
|
Acetylation | 9 | 2016 | 111 | 0.200 |
Why?
|
Neural Crest | 2 | 2013 | 29 | 0.200 |
Why?
|
Anaphase | 1 | 2022 | 33 | 0.200 |
Why?
|
Chromosome Segregation | 1 | 2022 | 39 | 0.200 |
Why?
|
Cell Division | 7 | 2022 | 442 | 0.200 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2016 | 416 | 0.200 |
Why?
|
Vitamin D Response Element | 5 | 2004 | 5 | 0.200 |
Why?
|
Gene Deletion | 5 | 2012 | 298 | 0.200 |
Why?
|
Bone Regeneration | 3 | 2012 | 14 | 0.190 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2001 | 27 | 0.190 |
Why?
|
Genes, Tumor Suppressor | 3 | 2013 | 73 | 0.190 |
Why?
|
Prognosis | 2 | 2024 | 1564 | 0.190 |
Why?
|
Growth Differentiation Factor 2 | 1 | 2021 | 1 | 0.190 |
Why?
|
Osteoarthritis | 1 | 2023 | 129 | 0.190 |
Why?
|
Nanostructures | 2 | 2024 | 174 | 0.190 |
Why?
|
Pre-B-Cell Leukemia Transcription Factor 1 | 2 | 2011 | 4 | 0.180 |
Why?
|
DNA Primers | 8 | 2010 | 291 | 0.180 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2017 | 16 | 0.180 |
Why?
|
Response Elements | 3 | 2016 | 42 | 0.180 |
Why?
|
Protein Isoforms | 7 | 2015 | 195 | 0.180 |
Why?
|
Minerals | 2 | 2011 | 19 | 0.180 |
Why?
|
Genes, Reporter | 8 | 2016 | 243 | 0.180 |
Why?
|
Mitochondria | 4 | 2011 | 333 | 0.180 |
Why?
|
Lung Neoplasms | 3 | 2017 | 546 | 0.180 |
Why?
|
Phosphorylation | 9 | 2016 | 861 | 0.180 |
Why?
|
Cyclin E | 3 | 2023 | 14 | 0.170 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2011 | 67 | 0.170 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2017 | 50 | 0.170 |
Why?
|
Cellular Senescence | 3 | 2011 | 103 | 0.170 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 1 | 2020 | 14 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2010 | 180 | 0.170 |
Why?
|
Genetic Markers | 2 | 2017 | 121 | 0.170 |
Why?
|
NIH 3T3 Cells | 6 | 2012 | 96 | 0.170 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2019 | 25 | 0.170 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2011 | 48 | 0.170 |
Why?
|
Adiponectin | 2 | 2020 | 34 | 0.170 |
Why?
|
Mutagenesis, Site-Directed | 6 | 2013 | 255 | 0.170 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 4 | 2009 | 4 | 0.170 |
Why?
|
Protein Interaction Domains and Motifs | 3 | 2017 | 83 | 0.170 |
Why?
|
HEK293 Cells | 4 | 2018 | 577 | 0.170 |
Why?
|
Transcription Factor AP-2 | 8 | 2005 | 12 | 0.160 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2019 | 37 | 0.160 |
Why?
|
S Phase | 5 | 2018 | 76 | 0.160 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 77 | 0.160 |
Why?
|
Leukemia, Myeloid | 3 | 2017 | 30 | 0.160 |
Why?
|
Integrin beta3 | 1 | 2019 | 9 | 0.160 |
Why?
|
Gene Silencing | 2 | 2012 | 377 | 0.160 |
Why?
|
Adipogenesis | 1 | 2020 | 71 | 0.160 |
Why?
|
RNA, Transfer | 1 | 2020 | 76 | 0.160 |
Why?
|
Introns | 2 | 2017 | 106 | 0.160 |
Why?
|
Chromosomes, Human | 2 | 2011 | 54 | 0.160 |
Why?
|
Histone Demethylases | 1 | 2018 | 11 | 0.160 |
Why?
|
Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 6 | 0.160 |
Why?
|
Co-Repressor Proteins | 3 | 2017 | 22 | 0.160 |
Why?
|
Histone Acetyltransferases | 3 | 2008 | 56 | 0.150 |
Why?
|
Genes, rRNA | 2 | 2008 | 7 | 0.150 |
Why?
|
DNA, Intergenic | 1 | 2017 | 23 | 0.150 |
Why?
|
Fractures, Spontaneous | 1 | 2017 | 7 | 0.150 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2017 | 6 | 0.150 |
Why?
|
Osteochondrodysplasias | 1 | 2017 | 11 | 0.150 |
Why?
|
Chromosome Disorders | 1 | 2017 | 14 | 0.150 |
Why?
|
Gene Ontology | 1 | 2017 | 37 | 0.150 |
Why?
|
Myeloid Progenitor Cells | 2 | 2009 | 12 | 0.150 |
Why?
|
G2 Phase | 2 | 2016 | 23 | 0.150 |
Why?
|
Bone Marrow Neoplasms | 1 | 2017 | 2 | 0.140 |
Why?
|
Oncogenes | 2 | 2017 | 68 | 0.140 |
Why?
|
Electrophoretic Mobility Shift Assay | 6 | 2010 | 64 | 0.140 |
Why?
|
Aggression | 1 | 2017 | 57 | 0.140 |
Why?
|
RNA, Small Untranslated | 1 | 2017 | 17 | 0.140 |
Why?
|
Microscopy | 2 | 2016 | 88 | 0.140 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2015 | 38 | 0.140 |
Why?
|
Nucleolus Organizer Region | 4 | 2010 | 7 | 0.140 |
Why?
|
WW Domain-Containing Oxidoreductase | 6 | 2016 | 6 | 0.140 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 2 | 2007 | 9 | 0.140 |
Why?
|
Matrix Attachment Regions | 1 | 2017 | 4 | 0.140 |
Why?
|
DNA Topoisomerases | 1 | 2017 | 4 | 0.140 |
Why?
|
Risk Assessment | 1 | 2024 | 1907 | 0.140 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2016 | 7 | 0.140 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 152 | 0.140 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2014 | 72 | 0.140 |
Why?
|
Cell Growth Processes | 3 | 2012 | 36 | 0.140 |
Why?
|
Pol1 Transcription Initiation Complex Proteins | 3 | 2012 | 8 | 0.140 |
Why?
|
RNA, Messenger, Stored | 1 | 2016 | 5 | 0.140 |
Why?
|
Synovial Membrane | 1 | 2016 | 19 | 0.140 |
Why?
|
Zygote | 1 | 2016 | 45 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 462 | 0.130 |
Why?
|
Serotonin | 1 | 2017 | 66 | 0.130 |
Why?
|
Ribonucleoproteins | 2 | 2010 | 112 | 0.130 |
Why?
|
Recombinant Proteins | 3 | 2009 | 694 | 0.130 |
Why?
|
Estrogens | 2 | 2022 | 113 | 0.130 |
Why?
|
Amino Acid Substitution | 2 | 2010 | 253 | 0.130 |
Why?
|
Leukemia | 2 | 2014 | 53 | 0.130 |
Why?
|
Prostate | 1 | 2016 | 54 | 0.130 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2015 | 8 | 0.130 |
Why?
|
Dronabinol | 2 | 2008 | 29 | 0.130 |
Why?
|
Collagen Type X | 2 | 2006 | 4 | 0.130 |
Why?
|
Collagen Type II | 2 | 2006 | 13 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2015 | 22 | 0.130 |
Why?
|
Osteocytes | 2 | 2005 | 12 | 0.130 |
Why?
|
Periodontitis | 1 | 2015 | 16 | 0.130 |
Why?
|
Stromal Cells | 3 | 2011 | 65 | 0.130 |
Why?
|
Interferon Regulatory Factors | 1 | 2015 | 39 | 0.130 |
Why?
|
Collagen Type I | 2 | 2019 | 39 | 0.130 |
Why?
|
Telomere | 1 | 2015 | 47 | 0.130 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2015 | 2 | 0.130 |
Why?
|
Recombinant Fusion Proteins | 9 | 2011 | 502 | 0.120 |
Why?
|
Cell Culture Techniques | 4 | 2010 | 177 | 0.120 |
Why?
|
Acetates | 2 | 2018 | 31 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 2 | 2 | 2018 | 18 | 0.120 |
Why?
|
Antineoplastic Agents | 2 | 2010 | 643 | 0.120 |
Why?
|
Cytoplasmic Structures | 1 | 2014 | 1 | 0.120 |
Why?
|
Polymerase Chain Reaction | 5 | 2017 | 500 | 0.120 |
Why?
|
Protein Subunits | 2 | 2006 | 164 | 0.120 |
Why?
|
Epigenomics | 2 | 2018 | 54 | 0.120 |
Why?
|
Myosin Heavy Chains | 1 | 2014 | 40 | 0.120 |
Why?
|
Histone Code | 3 | 2020 | 25 | 0.120 |
Why?
|
Mutant Proteins | 3 | 2010 | 105 | 0.120 |
Why?
|
Cytokinesis | 1 | 2014 | 39 | 0.120 |
Why?
|
Active Transport, Cell Nucleus | 7 | 2010 | 106 | 0.120 |
Why?
|
Integrin-Binding Sialoprotein | 3 | 2010 | 5 | 0.120 |
Why?
|
Nuclear Localization Signals | 3 | 2009 | 18 | 0.120 |
Why?
|
Immunohistochemistry | 4 | 2015 | 846 | 0.120 |
Why?
|
Mice, Mutant Strains | 4 | 2014 | 304 | 0.110 |
Why?
|
Fluorescent Antibody Technique | 5 | 2017 | 219 | 0.110 |
Why?
|
Reference Standards | 1 | 2014 | 61 | 0.110 |
Why?
|
Eukaryota | 1 | 2014 | 29 | 0.110 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2014 | 60 | 0.110 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2013 | 19 | 0.110 |
Why?
|
Mammary Glands, Human | 2 | 2015 | 50 | 0.110 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2014 | 28 | 0.110 |
Why?
|
Genes, Lethal | 3 | 2010 | 41 | 0.110 |
Why?
|
Sp7 Transcription Factor | 2 | 2011 | 6 | 0.110 |
Why?
|
Tissue Distribution | 3 | 2011 | 282 | 0.110 |
Why?
|
Macrophages | 3 | 2015 | 1006 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2013 | 52 | 0.110 |
Why?
|
Integrins | 1 | 2014 | 108 | 0.110 |
Why?
|
Feedback, Physiological | 2 | 2010 | 58 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2013 | 47 | 0.110 |
Why?
|
Bortezomib | 2 | 2010 | 54 | 0.110 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2013 | 12 | 0.110 |
Why?
|
Facial Bones | 1 | 2013 | 12 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 134 | 0.110 |
Why?
|
Ethanol | 1 | 2016 | 307 | 0.110 |
Why?
|
Craniosynostoses | 1 | 2013 | 11 | 0.110 |
Why?
|
Wound Healing | 1 | 2014 | 177 | 0.110 |
Why?
|
Cyclin D2 | 2 | 2010 | 6 | 0.100 |
Why?
|
Steroids | 2 | 2013 | 54 | 0.100 |
Why?
|
Arthritis, Rheumatoid | 1 | 2016 | 324 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 168 | 0.100 |
Why?
|
X-Ray Microtomography | 3 | 2022 | 26 | 0.100 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2010 | 16 | 0.100 |
Why?
|
CDC2 Protein Kinase | 2 | 2016 | 33 | 0.100 |
Why?
|
Structure-Activity Relationship | 3 | 2009 | 376 | 0.100 |
Why?
|
Hydroxyurea | 2 | 2009 | 24 | 0.100 |
Why?
|
Ribosomes | 1 | 2014 | 153 | 0.100 |
Why?
|
Growth Differentiation Factor 10 | 1 | 2012 | 1 | 0.100 |
Why?
|
Cell Line, Transformed | 3 | 2008 | 97 | 0.100 |
Why?
|
Epitopes | 2 | 2004 | 298 | 0.100 |
Why?
|
Ribonucleoproteins, Small Nuclear | 2 | 2009 | 20 | 0.100 |
Why?
|
GATA Transcription Factors | 1 | 2012 | 3 | 0.100 |
Why?
|
Surface Properties | 2 | 2024 | 270 | 0.100 |
Why?
|
Arthritis, Experimental | 1 | 2012 | 29 | 0.100 |
Why?
|
Dentin | 1 | 2012 | 2 | 0.100 |
Why?
|
Cyclins | 4 | 2007 | 40 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 185 | 0.100 |
Why?
|
Vitamin K | 1 | 2012 | 17 | 0.100 |
Why?
|
Histone Deacetylase 1 | 1 | 2012 | 18 | 0.100 |
Why?
|
Nanoparticles | 1 | 2018 | 496 | 0.100 |
Why?
|
Osteoporosis | 1 | 2013 | 137 | 0.100 |
Why?
|
Transcriptome | 3 | 2022 | 324 | 0.100 |
Why?
|
Extracellular Matrix Proteins | 1 | 2012 | 30 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2015 | 710 | 0.100 |
Why?
|
Obesity | 1 | 2020 | 1189 | 0.100 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 2008 | 75 | 0.100 |
Why?
|
Bone Diseases, Developmental | 1 | 2011 | 7 | 0.100 |
Why?
|
Health | 1 | 2011 | 32 | 0.100 |
Why?
|
Societies, Scientific | 1 | 2011 | 32 | 0.100 |
Why?
|
Early Growth Response Transcription Factors | 1 | 2011 | 1 | 0.100 |
Why?
|
Glycoproteins | 1 | 2012 | 193 | 0.090 |
Why?
|
Cytoplasm | 3 | 2010 | 273 | 0.090 |
Why?
|
Quinones | 1 | 2010 | 5 | 0.090 |
Why?
|
Amino Acid Motifs | 5 | 2010 | 152 | 0.090 |
Why?
|
Molecular Chaperones | 1 | 2011 | 97 | 0.090 |
Why?
|
Lactams | 1 | 2010 | 14 | 0.090 |
Why?
|
Tumor Burden | 1 | 2010 | 62 | 0.090 |
Why?
|
Metaphase | 3 | 2022 | 35 | 0.090 |
Why?
|
Blotting, Northern | 2 | 2008 | 148 | 0.090 |
Why?
|
Risk Factors | 2 | 2019 | 4997 | 0.090 |
Why?
|
Extremities | 1 | 2010 | 50 | 0.090 |
Why?
|
Plasmids | 2 | 2009 | 282 | 0.090 |
Why?
|
Multipotent Stem Cells | 1 | 2010 | 12 | 0.090 |
Why?
|
Growth Plate | 2 | 2008 | 14 | 0.090 |
Why?
|
Hematopoietic Stem Cells | 4 | 2017 | 275 | 0.090 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2010 | 80 | 0.090 |
Why?
|
Aromatase | 1 | 2010 | 16 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2016 | 130 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2009 | 4 | 0.090 |
Why?
|
Pyrimidines | 1 | 2010 | 123 | 0.090 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2009 | 7 | 0.090 |
Why?
|
Intracellular Space | 1 | 2010 | 32 | 0.090 |
Why?
|
Leukotriene B4 | 1 | 2009 | 13 | 0.090 |
Why?
|
Androgens | 1 | 2010 | 49 | 0.090 |
Why?
|
Granulocytes | 2 | 2009 | 67 | 0.080 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2009 | 10 | 0.080 |
Why?
|
Tetracycline | 1 | 2009 | 20 | 0.080 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2009 | 15 | 0.080 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 183 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2010 | 172 | 0.080 |
Why?
|
Positron-Emission Tomography | 1 | 2010 | 170 | 0.080 |
Why?
|
Sulfides | 1 | 2009 | 21 | 0.080 |
Why?
|
Bone Substitutes | 1 | 2009 | 16 | 0.080 |
Why?
|
Bony Callus | 1 | 2009 | 3 | 0.080 |
Why?
|
SOX9 Transcription Factor | 2 | 2006 | 8 | 0.080 |
Why?
|
RNA 3' End Processing | 1 | 2009 | 5 | 0.080 |
Why?
|
Quinolines | 1 | 2009 | 38 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2011 | 135 | 0.080 |
Why?
|
Deoxyribonuclease I | 2 | 2013 | 38 | 0.080 |
Why?
|
Elastomers | 1 | 2009 | 7 | 0.080 |
Why?
|
High Mobility Group Proteins | 2 | 2006 | 18 | 0.080 |
Why?
|
Kinetics | 4 | 2016 | 733 | 0.080 |
Why?
|
Cyclopropanes | 1 | 2009 | 41 | 0.080 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 2009 | 3 | 0.080 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 383 | 0.080 |
Why?
|
Sterols | 1 | 2009 | 6 | 0.080 |
Why?
|
Proteoglycans | 1 | 2009 | 33 | 0.080 |
Why?
|
Durapatite | 1 | 2009 | 24 | 0.080 |
Why?
|
Adult | 3 | 2015 | 15729 | 0.080 |
Why?
|
Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2009 | 31 | 0.080 |
Why?
|
Chromosome Breakage | 1 | 2009 | 7 | 0.080 |
Why?
|
Embryonic and Fetal Development | 3 | 2003 | 47 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2009 | 43 | 0.080 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 4 | 0.080 |
Why?
|
Receptors, Notch | 1 | 2009 | 100 | 0.080 |
Why?
|
Mammals | 1 | 2010 | 204 | 0.080 |
Why?
|
Genes, bcl-1 | 1 | 2008 | 2 | 0.080 |
Why?
|
Helix-Turn-Helix Motifs | 1 | 2008 | 2 | 0.080 |
Why?
|
Sp1 Transcription Factor | 1 | 2008 | 21 | 0.080 |
Why?
|
Fibroblast Growth Factors | 1 | 2009 | 63 | 0.080 |
Why?
|
Twist-Related Protein 1 | 1 | 2008 | 12 | 0.080 |
Why?
|
Zinc Finger Protein Gli2 | 1 | 2008 | 26 | 0.080 |
Why?
|
Parathyroid Glands | 1 | 2008 | 8 | 0.080 |
Why?
|
Carcinoma | 2 | 2007 | 117 | 0.080 |
Why?
|
Biomedical Research | 1 | 2011 | 250 | 0.080 |
Why?
|
Ectodermal Dysplasia | 1 | 2008 | 6 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2009 | 201 | 0.080 |
Why?
|
Parathyroid Hormone | 1 | 2008 | 43 | 0.080 |
Why?
|
Frameshift Mutation | 1 | 2008 | 28 | 0.080 |
Why?
|
Organ Size | 3 | 2015 | 163 | 0.080 |
Why?
|
Tissue Scaffolds | 1 | 2009 | 79 | 0.080 |
Why?
|
Histone Deacetylases | 2 | 2013 | 62 | 0.080 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 222 | 0.070 |
Why?
|
Blastocyst | 3 | 2016 | 76 | 0.070 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 197 | 0.070 |
Why?
|
Cannabinoids | 1 | 2008 | 34 | 0.070 |
Why?
|
Receptors, Retinoic Acid | 3 | 2002 | 55 | 0.070 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2007 | 1 | 0.070 |
Why?
|
Skeleton | 2 | 2006 | 3 | 0.070 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2007 | 3 | 0.070 |
Why?
|
Protein Stability | 2 | 2021 | 82 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2008 | 127 | 0.070 |
Why?
|
Cyclin B | 1 | 2007 | 17 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 29 | 0.070 |
Why?
|
Phosphoserine | 1 | 2007 | 10 | 0.070 |
Why?
|
Luciferases | 3 | 2014 | 109 | 0.070 |
Why?
|
E2F Transcription Factors | 1 | 2007 | 16 | 0.070 |
Why?
|
Precipitin Tests | 2 | 2004 | 79 | 0.070 |
Why?
|
Genes, cdc | 1 | 2007 | 14 | 0.070 |
Why?
|
Cell Communication | 2 | 2004 | 129 | 0.070 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2007 | 42 | 0.070 |
Why?
|
Absorptiometry, Photon | 1 | 2007 | 89 | 0.070 |
Why?
|
Carotid Arteries | 1 | 2007 | 59 | 0.070 |
Why?
|
Angioplasty, Balloon | 1 | 2007 | 56 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 238 | 0.070 |
Why?
|
Organ Specificity | 3 | 2017 | 178 | 0.070 |
Why?
|
Databases, Genetic | 2 | 2017 | 82 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2016 | 2061 | 0.070 |
Why?
|
Proteolysis | 2 | 2021 | 138 | 0.070 |
Why?
|
Protein Sorting Signals | 2 | 2006 | 57 | 0.070 |
Why?
|
Smad5 Protein | 2 | 2005 | 7 | 0.070 |
Why?
|
Spermatozoa | 1 | 2008 | 252 | 0.070 |
Why?
|
Conserved Sequence | 2 | 2008 | 171 | 0.070 |
Why?
|
RNA Splice Sites | 1 | 2006 | 22 | 0.070 |
Why?
|
RNA Polymerase II | 3 | 2011 | 70 | 0.070 |
Why?
|
Caspase 3 | 3 | 2016 | 105 | 0.070 |
Why?
|
Peptide Fragments | 3 | 2016 | 353 | 0.070 |
Why?
|
Ubiquitination | 2 | 2021 | 106 | 0.070 |
Why?
|
beta Catenin | 1 | 2006 | 85 | 0.070 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2005 | 9 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 40 | 0.060 |
Why?
|
Cell Nucleolus | 3 | 2012 | 68 | 0.060 |
Why?
|
Fluorescence Recovery After Photobleaching | 3 | 2011 | 25 | 0.060 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2005 | 10 | 0.060 |
Why?
|
Aging | 1 | 2011 | 722 | 0.060 |
Why?
|
Tubulin | 1 | 2006 | 74 | 0.060 |
Why?
|
Mediator Complex Subunit 1 | 3 | 2010 | 7 | 0.060 |
Why?
|
DNA, Complementary | 1 | 2005 | 166 | 0.060 |
Why?
|
Myeloid Cells | 1 | 2006 | 92 | 0.060 |
Why?
|
DNA, Ribosomal | 3 | 2012 | 29 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2011 | 155 | 0.060 |
Why?
|
Adenoviridae | 1 | 2005 | 119 | 0.060 |
Why?
|
Immunoprecipitation | 3 | 2010 | 116 | 0.060 |
Why?
|
Coculture Techniques | 1 | 2024 | 93 | 0.060 |
Why?
|
CRISPR-Cas Systems | 2 | 2021 | 325 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 57 | 0.060 |
Why?
|
Microtubules | 1 | 2006 | 211 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2013 | 963 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2010 | 810 | 0.060 |
Why?
|
Procollagen | 2 | 2016 | 10 | 0.060 |
Why?
|
Uridine Triphosphate | 1 | 2004 | 2 | 0.060 |
Why?
|
Cell Fractionation | 4 | 2005 | 31 | 0.060 |
Why?
|
Paraffin Embedding | 1 | 2003 | 16 | 0.060 |
Why?
|
Tissue Fixation | 1 | 2003 | 23 | 0.060 |
Why?
|
Sequence Alignment | 1 | 2004 | 290 | 0.060 |
Why?
|
Lasers | 1 | 2003 | 33 | 0.060 |
Why?
|
Prostate-Specific Antigen | 2 | 2018 | 66 | 0.060 |
Why?
|
DNA, Neoplasm | 3 | 2013 | 51 | 0.060 |
Why?
|
Biochemistry | 1 | 2004 | 50 | 0.060 |
Why?
|
Tyrosine | 1 | 2004 | 95 | 0.060 |
Why?
|
Karyotyping | 2 | 2017 | 45 | 0.050 |
Why?
|
Acetyltransferases | 1 | 2003 | 24 | 0.050 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2003 | 14 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2004 | 124 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2018 | 450 | 0.050 |
Why?
|
Mandible | 2 | 2013 | 12 | 0.050 |
Why?
|
Cancellous Bone | 1 | 2022 | 4 | 0.050 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2022 | 15 | 0.050 |
Why?
|
Doxycycline | 1 | 2022 | 41 | 0.050 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 47 | 0.050 |
Why?
|
Survival Analysis | 2 | 2018 | 553 | 0.050 |
Why?
|
Morphine | 1 | 2022 | 52 | 0.050 |
Why?
|
Eukaryotic Cells | 1 | 2002 | 55 | 0.050 |
Why?
|
Hypotrichosis | 1 | 2002 | 4 | 0.050 |
Why?
|
Ligands | 3 | 2010 | 422 | 0.050 |
Why?
|
Consensus Sequence | 1 | 2002 | 28 | 0.050 |
Why?
|
RNA Splicing | 1 | 2003 | 161 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2001 | 1 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 124 | 0.050 |
Why?
|
Infertility, Male | 1 | 2002 | 58 | 0.050 |
Why?
|
Methylation | 1 | 2021 | 126 | 0.050 |
Why?
|
Genetic Loci | 2 | 2012 | 106 | 0.050 |
Why?
|
Spindle Apparatus | 1 | 2022 | 123 | 0.050 |
Why?
|
Adipocytes | 2 | 2015 | 252 | 0.050 |
Why?
|
Cross-Linking Reagents | 2 | 2017 | 112 | 0.050 |
Why?
|
Cell Hypoxia | 1 | 2021 | 39 | 0.050 |
Why?
|
Cell Compartmentation | 3 | 2007 | 34 | 0.050 |
Why?
|
CpG Islands | 1 | 2002 | 212 | 0.050 |
Why?
|
Acute Disease | 2 | 2017 | 658 | 0.040 |
Why?
|
Gene Targeting | 2 | 2013 | 82 | 0.040 |
Why?
|
Isoenzymes | 2 | 2012 | 134 | 0.040 |
Why?
|
Interleukin-3 | 2 | 2010 | 21 | 0.040 |
Why?
|
Green Fluorescent Proteins | 3 | 2011 | 353 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2011 | 211 | 0.040 |
Why?
|
Cell Count | 2 | 2011 | 129 | 0.040 |
Why?
|
Fatty Acid Desaturases | 1 | 2020 | 5 | 0.040 |
Why?
|
Heterografts | 1 | 2020 | 60 | 0.040 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2020 | 21 | 0.040 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2020 | 13 | 0.040 |
Why?
|
Macromolecular Substances | 3 | 2006 | 160 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2020 | 83 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2020 | 22 | 0.040 |
Why?
|
Molecular Weight | 2 | 2010 | 187 | 0.040 |
Why?
|
Methylene Chloride | 1 | 2019 | 3 | 0.040 |
Why?
|
Hexanes | 1 | 2019 | 3 | 0.040 |
Why?
|
RNA Polymerase I | 2 | 2011 | 9 | 0.040 |
Why?
|
PPAR gamma | 1 | 2020 | 71 | 0.040 |
Why?
|
Leptin | 1 | 2020 | 78 | 0.040 |
Why?
|
E-Box Elements | 2 | 2009 | 4 | 0.040 |
Why?
|
Intermediate Filaments | 2 | 2010 | 8 | 0.040 |
Why?
|
NF-kappa B | 2 | 2015 | 461 | 0.040 |
Why?
|
Cattle | 2 | 2015 | 306 | 0.040 |
Why?
|
Retinoid X Receptors | 3 | 2004 | 14 | 0.040 |
Why?
|
1-Butanol | 1 | 2018 | 4 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2017 | 1546 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2001 | 580 | 0.040 |
Why?
|
RNA Stability | 2 | 2011 | 93 | 0.040 |
Why?
|
Colony-Forming Units Assay | 2 | 2011 | 23 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2019 | 178 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 23 | 0.040 |
Why?
|
Ovary | 2 | 2008 | 96 | 0.040 |
Why?
|
Ring Chromosomes | 1 | 2017 | 1 | 0.040 |
Why?
|
Chromosome Banding | 1 | 2017 | 10 | 0.040 |
Why?
|
Protein Biosynthesis | 2 | 2012 | 292 | 0.040 |
Why?
|
CHO Cells | 2 | 2010 | 191 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 20 | 0.040 |
Why?
|
Mosaicism | 1 | 2017 | 25 | 0.040 |
Why?
|
Cytogenetic Analysis | 1 | 2017 | 24 | 0.040 |
Why?
|
Nuclear Receptor Coactivator 1 | 2 | 2008 | 5 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2013 | 671 | 0.040 |
Why?
|
Cell Nucleus Shape | 1 | 2017 | 5 | 0.040 |
Why?
|
Heterozygote | 2 | 2009 | 168 | 0.040 |
Why?
|
Jurkat Cells | 2 | 2010 | 102 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 493 | 0.040 |
Why?
|
Cricetinae | 2 | 2010 | 377 | 0.040 |
Why?
|
A549 Cells | 1 | 2017 | 36 | 0.040 |
Why?
|
Stem Cell Niche | 1 | 2017 | 12 | 0.040 |
Why?
|
Body Weight | 2 | 2011 | 378 | 0.040 |
Why?
|
Exons | 2 | 2010 | 193 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 29 | 0.040 |
Why?
|
Serotonin Receptor Agonists | 1 | 2017 | 12 | 0.040 |
Why?
|
Receptors, Serotonin | 1 | 2017 | 17 | 0.030 |
Why?
|
Synoviocytes | 1 | 2016 | 1 | 0.030 |
Why?
|
Serotonin Antagonists | 1 | 2017 | 31 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2017 | 82 | 0.030 |
Why?
|
Mutagenesis | 2 | 2008 | 129 | 0.030 |
Why?
|
Embryo Implantation | 1 | 2016 | 23 | 0.030 |
Why?
|
Triiodothyronine | 1 | 2016 | 26 | 0.030 |
Why?
|
Orchiectomy | 1 | 2016 | 28 | 0.030 |
Why?
|
In Situ Hybridization | 2 | 2007 | 215 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 24 | 0.030 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 5 | 0.030 |
Why?
|
Transduction, Genetic | 2 | 2010 | 233 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2016 | 78 | 0.030 |
Why?
|
Porphyromonas gingivalis | 1 | 2015 | 16 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2015 | 32 | 0.030 |
Why?
|
Endoderm | 1 | 2016 | 51 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2017 | 133 | 0.030 |
Why?
|
RAW 264.7 Cells | 1 | 2015 | 47 | 0.030 |
Why?
|
Chromosome Fragility | 1 | 2015 | 2 | 0.030 |
Why?
|
Lipogenesis | 1 | 2016 | 65 | 0.030 |
Why?
|
Zinc Fingers | 2 | 2008 | 95 | 0.030 |
Why?
|
Mice, Obese | 1 | 2015 | 79 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 113 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 89 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 99 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2016 | 250 | 0.030 |
Why?
|
DNA Polymerase I | 1 | 2014 | 5 | 0.030 |
Why?
|
Nanog Homeobox Protein | 1 | 2015 | 10 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2015 | 16 | 0.030 |
Why?
|
ATPases Associated with Diverse Cellular Activities | 1 | 2015 | 25 | 0.030 |
Why?
|
Myosin Light Chains | 1 | 2014 | 7 | 0.030 |
Why?
|
Annexin A5 | 2 | 2005 | 23 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2008 | 880 | 0.030 |
Why?
|
Polyploidy | 1 | 2014 | 11 | 0.030 |
Why?
|
Synteny | 1 | 2014 | 24 | 0.030 |
Why?
|
Genotype | 2 | 2009 | 644 | 0.030 |
Why?
|
Cranial Fontanelles | 1 | 2014 | 1 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2014 | 16 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2017 | 1058 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2014 | 111 | 0.030 |
Why?
|
Myoblasts | 1 | 2015 | 63 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 125 | 0.030 |
Why?
|
NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2013 | 3 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2014 | 29 | 0.030 |
Why?
|
Lipids | 1 | 2016 | 305 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 324 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 102 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 396 | 0.030 |
Why?
|
Gamma Rays | 1 | 2013 | 31 | 0.030 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2013 | 12 | 0.030 |
Why?
|
Lymphopoiesis | 1 | 2013 | 25 | 0.030 |
Why?
|
Ubiquitin | 1 | 2013 | 95 | 0.030 |
Why?
|
Genes, myc | 1 | 2013 | 19 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2013 | 41 | 0.030 |
Why?
|
Models, Animal | 1 | 2013 | 220 | 0.030 |
Why?
|
Tartrate-Resistant Acid Phosphatase | 1 | 2012 | 1 | 0.030 |
Why?
|
Acid Phosphatase | 1 | 2012 | 4 | 0.030 |
Why?
|
Luminescent Proteins | 2 | 2002 | 129 | 0.030 |
Why?
|
Vitamin K Deficiency | 1 | 2012 | 2 | 0.030 |
Why?
|
Dentin Dysplasia | 1 | 2012 | 1 | 0.030 |
Why?
|
Odontoblasts | 1 | 2012 | 1 | 0.030 |
Why?
|
Luciferases, Renilla | 1 | 2012 | 3 | 0.030 |
Why?
|
Tooth | 1 | 2012 | 4 | 0.030 |
Why?
|
Models, Molecular | 2 | 2008 | 1125 | 0.030 |
Why?
|
Ameloblasts | 1 | 2012 | 2 | 0.030 |
Why?
|
Dental Enamel | 1 | 2012 | 2 | 0.030 |
Why?
|
Homozygote | 2 | 2002 | 117 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 645 | 0.030 |
Why?
|
Follistatin-Related Proteins | 1 | 2012 | 22 | 0.030 |
Why?
|
Methyltransferases | 1 | 2012 | 50 | 0.030 |
Why?
|
Joints | 1 | 2012 | 30 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2012 | 36 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 174 | 0.020 |
Why?
|
Adolescent | 2 | 2017 | 5914 | 0.020 |
Why?
|
Cellular Microenvironment | 1 | 2011 | 20 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2012 | 98 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2011 | 34 | 0.020 |
Why?
|
SMARCB1 Protein | 1 | 2010 | 10 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2010 | 23 | 0.020 |
Why?
|
Benzoquinones | 1 | 2010 | 14 | 0.020 |
Why?
|
Femur | 1 | 2011 | 53 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2010 | 83 | 0.020 |
Why?
|
Video Recording | 1 | 2011 | 125 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2010 | 25 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2004 | 636 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 70 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2013 | 550 | 0.020 |
Why?
|
Flavonoids | 1 | 2010 | 73 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 2010 | 17 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2010 | 21 | 0.020 |
Why?
|
Leupeptins | 1 | 2009 | 16 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 102 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2010 | 50 | 0.020 |
Why?
|
Transcription Factor HES-1 | 1 | 2009 | 6 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2009 | 21 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2009 | 105 | 0.020 |
Why?
|
Mice, Nude | 1 | 2010 | 259 | 0.020 |
Why?
|
Proteasome Inhibitors | 1 | 2009 | 30 | 0.020 |
Why?
|
Autocrine Communication | 1 | 2010 | 31 | 0.020 |
Why?
|
Myoblasts, Skeletal | 1 | 2009 | 12 | 0.020 |
Why?
|
Protein Folding | 1 | 2011 | 256 | 0.020 |
Why?
|
Integrin alphaV | 1 | 2009 | 2 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2009 | 104 | 0.020 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 43 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2015 | 766 | 0.020 |
Why?
|
Freeze Drying | 1 | 2009 | 13 | 0.020 |
Why?
|
Powders | 1 | 2009 | 19 | 0.020 |
Why?
|
Compressive Strength | 1 | 2009 | 18 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2010 | 167 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2009 | 124 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2009 | 25 | 0.020 |
Why?
|
Caspase 8 | 1 | 2009 | 61 | 0.020 |
Why?
|
Progesterone | 1 | 2010 | 157 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2010 | 201 | 0.020 |
Why?
|
Clavicle | 1 | 2008 | 4 | 0.020 |
Why?
|
Aneuploidy | 1 | 2009 | 37 | 0.020 |
Why?
|
Cell Polarity | 1 | 2009 | 110 | 0.020 |
Why?
|
Sex Determination Processes | 1 | 2008 | 8 | 0.020 |
Why?
|
Lac Operon | 1 | 2008 | 26 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2009 | 111 | 0.020 |
Why?
|
Snail Family Transcription Factors | 1 | 2008 | 25 | 0.020 |
Why?
|
Pituitary Gland | 1 | 2008 | 49 | 0.020 |
Why?
|
Drug Discovery | 1 | 2009 | 91 | 0.020 |
Why?
|
Motor Activity | 1 | 2011 | 342 | 0.020 |
Why?
|
Sperm Motility | 1 | 2008 | 46 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 2008 | 81 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2008 | 66 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 2008 | 98 | 0.020 |
Why?
|
Myogenin | 1 | 2008 | 16 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2008 | 64 | 0.020 |
Why?
|
MyoD Protein | 1 | 2008 | 43 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2008 | 47 | 0.020 |
Why?
|
Proteomics | 1 | 2010 | 252 | 0.020 |
Why?
|
Syndrome | 1 | 2008 | 173 | 0.020 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2008 | 61 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2008 | 357 | 0.020 |
Why?
|
Diatrizoate | 1 | 2007 | 4 | 0.020 |
Why?
|
Ficoll | 1 | 2007 | 4 | 0.020 |
Why?
|
Mimosine | 1 | 2007 | 1 | 0.020 |
Why?
|
Testis | 1 | 2008 | 137 | 0.020 |
Why?
|
Aphidicolin | 1 | 2007 | 7 | 0.020 |
Why?
|
Coiled Bodies | 1 | 2007 | 4 | 0.020 |
Why?
|
Biological Clocks | 1 | 2008 | 69 | 0.020 |
Why?
|
Nocodazole | 1 | 2007 | 15 | 0.020 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2008 | 37 | 0.020 |
Why?
|
Water | 1 | 2009 | 295 | 0.020 |
Why?
|
Muscles | 1 | 2008 | 171 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 265 | 0.020 |
Why?
|
Okadaic Acid | 1 | 2007 | 9 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2008 | 83 | 0.020 |
Why?
|
E2F4 Transcription Factor | 1 | 2007 | 2 | 0.020 |
Why?
|
Cell Shape | 1 | 2007 | 13 | 0.020 |
Why?
|
Crystallization | 1 | 2007 | 97 | 0.020 |
Why?
|
Purines | 1 | 2007 | 39 | 0.020 |
Why?
|
Hyperplasia | 1 | 2007 | 85 | 0.020 |
Why?
|
Chromatids | 1 | 2007 | 13 | 0.020 |
Why?
|
Hippocampus | 1 | 2008 | 238 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 182 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 77 | 0.020 |
Why?
|
Lymphoma | 1 | 2007 | 98 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2007 | 353 | 0.020 |
Why?
|
Dimethyl Sulfoxide | 1 | 2006 | 17 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2006 | 51 | 0.020 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 6 | 0.020 |
Why?
|
Dinoprostone | 1 | 2005 | 45 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 569 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2005 | 140 | 0.020 |
Why?
|
Paclitaxel | 1 | 2006 | 89 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2006 | 184 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 2352 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2008 | 384 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2007 | 280 | 0.020 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2005 | 6 | 0.020 |
Why?
|
Collagenases | 1 | 2005 | 14 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 5063 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2006 | 179 | 0.020 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2004 | 3 | 0.020 |
Why?
|
Peroxidase | 1 | 2005 | 69 | 0.010 |
Why?
|
Rod Cell Outer Segment | 1 | 2004 | 7 | 0.010 |
Why?
|
Genes, Regulator | 1 | 2004 | 27 | 0.010 |
Why?
|
Cell Physiological Phenomena | 1 | 2004 | 12 | 0.010 |
Why?
|
DNA Footprinting | 1 | 2004 | 16 | 0.010 |
Why?
|
Chloroform | 1 | 2003 | 6 | 0.010 |
Why?
|
Acetic Acid | 1 | 2003 | 10 | 0.010 |
Why?
|
Telophase | 1 | 2003 | 5 | 0.010 |
Why?
|
Fixatives | 1 | 2003 | 17 | 0.010 |
Why?
|
Methanol | 1 | 2003 | 12 | 0.010 |
Why?
|
Serine-Arginine Splicing Factors | 1 | 2003 | 14 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 2004 | 39 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2003 | 27 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2004 | 60 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2004 | 99 | 0.010 |
Why?
|
Dissection | 1 | 2003 | 44 | 0.010 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2003 | 20 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 190 | 0.010 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2003 | 2 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2003 | 35 | 0.010 |
Why?
|
Specimen Handling | 1 | 2004 | 57 | 0.010 |
Why?
|
p300-CBP Transcription Factors | 1 | 2003 | 10 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2004 | 140 | 0.010 |
Why?
|
COS Cells | 1 | 2003 | 174 | 0.010 |
Why?
|
Antibodies | 1 | 2004 | 177 | 0.010 |
Why?
|
Core Binding Factors | 1 | 2002 | 1 | 0.010 |
Why?
|
Histone Deacetylase 6 | 1 | 2002 | 7 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 2004 | 475 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2002 | 66 | 0.010 |
Why?
|
Species Specificity | 1 | 2003 | 336 | 0.010 |
Why?
|
Fetus | 1 | 2002 | 97 | 0.010 |
Why?
|
Molecular Structure | 1 | 2003 | 375 | 0.010 |
Why?
|
Dermis | 1 | 2002 | 16 | 0.010 |
Why?
|
Caspases | 1 | 2003 | 164 | 0.010 |
Why?
|
Digestive System | 1 | 2002 | 25 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 669 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2002 | 15 | 0.010 |
Why?
|
Cycloheximide | 1 | 2001 | 21 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2001 | 25 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 385 | 0.010 |
Why?
|
Dimerization | 1 | 2002 | 146 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 2002 | 92 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2001 | 90 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 172 | 0.010 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2002 | 248 | 0.010 |
Why?
|
Alleles | 1 | 2002 | 425 | 0.010 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2001 | 87 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2004 | 242 | 0.010 |
Why?
|
Antirheumatic Agents | 1 | 2003 | 213 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 338 | 0.010 |
Why?
|
Cytokines | 1 | 2004 | 906 | 0.010 |
Why?
|
Aged | 1 | 2015 | 13285 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 869 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2003 | 418 | 0.010 |
Why?
|
Liver | 1 | 2002 | 784 | 0.010 |
Why?
|
Middle Aged | 1 | 2015 | 16232 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2008 | 5141 | 0.010 |
Why?
|
Child | 1 | 2006 | 4298 | 0.010 |
Why?
|